Acurx Pharmaceuticals Inc. (ACXP) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Acurx Pharmaceuticals Inc...

    NASDAQ: ACXP · Real-Time Price · USD
    4.59
    0.03 (0.66%)
    At close: Oct 03, 2025, 3:56 PM
    4.55
    -0.87%
    After-hours: Oct 03, 2025, 05:39 PM EDT

    Acurx Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 3.71M 7.47M 9.11M 12.96M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a n/a n/a
    Receivables
    		 51.13K 129.16K n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 n/a n/a n/a n/a
    Total Current Assets
    		 3.86M 7.71M 9.38M 13.25M
    Property-Plant & Equipment
    		 n/a n/a n/a n/a
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 n/a n/a n/a n/a
    Total Assets
    		 3.86M 7.71M 9.38M 13.25M
    Account Payables
    		 n/a n/a n/a n/a
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 537.63K 716.31K 542.89K 508.34K
    Total Current Liabilities
    		 3.24M 3.04M 2.06M 843.91K
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Liabilities
    		 3.24M 3.04M 2.06M 843.91K
    Total Debt
    		 n/a n/a n/a n/a
    Book Value
    		 615.12K 4.67M 7.32M 12.41M
    Book Value Per Share
    		 0.72 7.37 13.53 24.30
    Common Stock
    		 17.03K 14.47K 11.63K 10.22K
    Retained Earnings
    		 -67.32M -53.22M -38.64M -26.55M
    Comprehensive Income
    		 n/a n/a -38.64M -26.55M
    Shareholders Equity
    		 615.12K 4.67M 7.32M 12.41M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist